Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Rating) was the recipient of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 268,200 shares, a decrease of 16.2% from the February 28th total of 320,000 shares. Approximately 1.6% of the shares of the company are short sold. Based […]